POEM- Peroral Endoscopic Myotomy for Esophageal Motility Disorders
Not Applicable
- Conditions
- Achalasia
- Registration Number
- NCT01512719
- Lead Sponsor
- Hadassah Medical Organization
- Brief Summary
POEM has recently described as an alternative treatment for achalasia in humans. In this procedure the esophageal sphincter is incised through a submucosal tunnel in the esophagus. In this study we aim to perform POEM on achalasia patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
- Patients with Achalasia whom are candidates for Heller Myotomy
Exclusion Criteria
- Perforation of LES during dilatation
- Pregnant women
- mentally ill patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Resolution of dysphagia up to 6 months postoperatively
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of peroral endoscopic myotomy in treating achalasia?
How does POEM compare to laparoscopic Heller myotomy in achalasia treatment outcomes?
Which biomarkers correlate with successful esophageal sphincter incision in POEM procedures?
What are the long-term adverse events associated with submucosal tunneling in POEM?
Are there combination therapies involving POEM for refractory achalasia or related motility disorders?
Trial Locations
- Locations (3)
Hadassah Medical Center
🇮🇱Jerusalem, Israel
Hadassah Medical Organization
🇮🇱Jerusalem, Israel
Hadassah Medical Organization Ein-Kerem campus
🇮🇱Jerusalem, Israel
Hadassah Medical Center🇮🇱Jerusalem, IsraelYoav Mintz, Associate Professor of SurgeryPrincipal InvestigatorRonit UngarContact+972-26779694ronitu@hadassah.org.il